Analyst firms · Morgan Stanley · VITL
Morgan Stanley VITL price target and rating history
Vital Farms Inc. (VITL) · Consumer Staples
Morgan Stanley rates Vital Farms Inc. (VITL) Equal-Weight with a $24 price target, as of its latest action on Feb 27, 2026. It has published 3 rating actions on VITL since July 2022, including 1 upgrade and 1 downgrade. Across 7 firms with a VITL price target in the last 12 months, the median target is $16. Morgan Stanley's $24 is 50% above that.
- Current rating
- Equal-Weight
- Price target
- $24
- Median target, all firms
- $16
- Actions on VITL
- 3
Morgan Stanley price target on VITL
Every Morgan Stanley rating on VITL
- Feb 27, 2026
- Mar 24, 2025
- Jul 20, 2022
How other firms rate VITL
Each firm's latest rating and stated target in the last 12 months.
| Firm | Rating | Price target | Date |
|---|---|---|---|
| Craig-Hallum | Buy | $12 | Nov 3, 2026 |
| The Benchmark Company | Buy | Aug 6, 2026 | |
| Telsey Advisory Group | Market Perform | $11 | May 8, 2026 |
| Stifel | Hold | $10 | May 8, 2026 |
| DA Davidson | Neutral | $16 | May 4, 2026 |
| TD Cowen | Hold | $16 | Apr 8, 2026 |
| Morgan Stanley | Equal-Weight | $24 | Feb 27, 2026 |
| Needham | Buy | $45 | Dec 5, 2025 |
Questions about Morgan Stanley and VITL
- What is Morgan Stanley's price target for VITL?
- Morgan Stanley's latest stated price target for Vital Farms Inc. (VITL) is $24, from its action on Feb 27, 2026.
- What is Morgan Stanley's rating on VITL?
- Morgan Stanley rates VITL Equal-Weight, a neutral rating, as of Feb 27, 2026.
- When did Morgan Stanley last change its view on VITL?
- On Feb 27, 2026, Morgan Stanley downgrades to Equal-Weight from Overweight, price target $24.
- How does Morgan Stanley's VITL target compare with other analysts?
- Across 7 firms with a VITL price target in the last 12 months, the median target is $16. Morgan Stanley's $24 is 50% above that.
More VITL rating histories
All Morgan Stanley ratingsVITL news and filingsEvery analyst firm
From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.